CMI_LatestReportOrientedBlogs

Plasmid DNA Manufacturing Market Plasmid DNA is a small, circular DNA molecule found in bacteria and some other unicellular organisms. Plasmids are used in genetic engineering and gene therapy as they are able to replicate independently of chromosomal DNA. Plasmids are engineered for use in bacterial cloning and gene expression. They are important tools for various biotechnological and medical applications including the development and manufacturing of gene therapies. The global plasmid DNA manufacturing market is estimated to be valued at US$ 901.2 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The opportunity for developing gene therapies is driving the growth of the plasmid DNA manufacturing market. Gene therapies involve the introduction, elimination, or correction of defective genes responsible for diseases. Plasmid DNA plays a key role as a

Oligonucleotide Synthesis Market Oligonucleotide synthesis involves chemical bonding between nucleotides that allows construction of desired DNA or RNA polymers needed for various research and medical applications. Rapid customization and cost-effective production has increased the adoption of oligonucleotides in research areas such as genetic testing, molecular diagnostics, gene therapy and forensic application. The Global Oligonucleotide Synthesis Market is estimated to be valued at US$ 3962.67 Mn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand for oligonucleotides from research and development applications is the major factor driving the growth of Oligonucleotide Synthesis Market. Growing research activities in areas of gene therapy, genetic testing and precision medicine has fueled the demand for tailored oligonucleotides. Acco

rHu Albumin Market Recombinant human albumin (rHu Albumin) is a sterile clear colorless solution essentially consisting of purified albumin produced from yeast. rHu Albumin is used as a volume expander in surgery, burns, shock, trauma, and other conditions and has advantages such as low risk of infection and allergic reactions. With rising healthcare expenditure and growing number of surgeries, the demand for rHu Albumin is increasing. The global rHu Albumin Market is estimated to be valued at US$ 14.16 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Growing geriatric population which is more prone towards various diseases and conditions requiring surgical interventions and critical care is expected to drive the global rHu Albumin market over the forecast period. According to the United Nations Population Fund (UNFPA), the number of people aged 65 yea

Third Generation Sequencing Market Third generation sequencing, also known as single-molecule real-time (SMRT) sequencing, enables scientists to directly observe DNA synthesis as it happens. Third generation sequencers have the ability to read long strands of DNA or RNA without having to piece them back together, providing researchers with important structural and genetic insights. The technology is enabling advances in precision medicine like disease diagnosis, monitoring disease progression, and development of targeted therapies. The global third generation sequencing market provides products like instruments, consumables, services, software for applications like DNA/RNA sequencing, epigenetics, detection of unknown/novel pathogens and others. The global third generation sequencing Market is estimated to be valued at US$ 10.1 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insight

Tissue Banking Market Tissue banking refers to the storing, preserving and distributing of human and animal tissues for the purpose of performing medical research and treating ailments and injuries that involve transplantation of tissues like bone, skin, heart valves, tendons and ligaments. There has been a rising demand for tissues used in regenerative medicine treatments and surgeries. With the growing geriatric population and rising cases of trauma injuries and chronic diseases, regenerative medicine using tissues has gained increased prominence. The Global Tissue Banking Market is estimated to be valued at US$ 1.81 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: With growing applications of stem cell research and regenerative medicine, the demand for high-quality tissues with intact viability is increasing. Tissue banks help in storing tissues saf

Platelet Rich Plasma Market The Platelet Rich Plasma Market is estimated to be valued at US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 12.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Platelet rich plasma (PRP) refers to concentrate obtained from the blood containing a higher number of platelets than normal blood. PRP therapy uses concentrated platelet-rich gel injected into injured tissues for faster healing and pain relief. It is increasingly used after surgeries to enhance tissue regeneration, repair of injured muscles, ligaments and tendons. PRP helps stimulate repair of damaged tissues by releasing various growth factors. Market key trends: Surging demand from sports medicine and treatment of orthopedic disorders are projected to drive the platelet rich plasma market growth. PRP therapy is commonly used to treat orthopedic conditions such as tennis elbow, rotator cuff injuries, Achilles

Remicade Biosimilars Market Remicade biosimilars are biologics drugs that are developed to be similar to an existing biologic drug (in this case infliximab, sold under the brand name Remicade) that is manufactured by a different company. Remicade biosimilars offer more treatment options for diseases like Crohn’s disease, ulcerative colitis, rheumatoid arthritis and other diseases treated with infliximab. They provide a more affordable alternative to the original biologic drug. The Remicade Biosimilars Market is estimated to be valued at US$ 3,007.28 Mn in 2023 and is expected to exhibit a CAGR of 35.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Growing prevalence of inflammatory bowel disease (IBD) and other autoimmune disorders is a key factor driving the demand for biosimilar versions of Remicade. IBD incidence rates continue to rise globally, especially in developed nations. For instance, accordi

Occupational Health Market The Occupational Health Market is estimated to be valued at US$ 104.18 Bn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Occupational health involves the protection and promotion of health related to work and working environment. It deals with identifying and reducing workplace health hazards and improving overall safety culture and environment. The market offers various solutions and products such as software, services and equipment that help monitor, track and improve employee health and prevent workplace injuries and illnesses. Market key trends: The market is witnessing high growth owing to increasing adoption of digital healthcare solutions across various industry verticals. Digital healthcare solutions help in streamlining workflows, reduce costs, improve productivity and enhance patient experience. Digital solutions also help

Immuno-Oncology Assays Market The Immuno-Oncology Assays Market is estimated to be valued at US$ 4556.83 Mn or Bn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Immuno-oncology assays are tests that are used to detect various biomarkers associated with cancer immune mechanisms. These assays are primarily used in cancer research to understand tumor microenvironment, identify potential drug targets, and guide immunotherapy. The major types of immuno-oncology assays include ELISA, flow cytometry, PCR, and next-generation sequencing. These assays help evaluate immune responses by quantifying immune cell populations, biomarkers, mutations, and expression profiles. Market Dynamics: Growing adoption of immunotherapies for cancer treatment due to their high efficacy and minimal side effects is a major driver for the immuno-oncology assays market. Immunotherapies

Immunology Market The Immunology Market is estimated to be valued at US$ 91,850 Million in 2021 and is expected to exhibit a CAGR of 8% over the forecast period 2021–2028, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Immunology Market encompasses the study and treatment of immune system disorders and diseases. The market offers a wide range of products such as immunosuppressants, immunomodulators, monoclonal antibodies, and vaccines, among others. These products find applications in the treatment of autoimmune diseases, inflammatory disorders, and cancer, among others. With the increasing prevalence of chronic diseases and the growing aging population, the demand for immunology products is expected to witness significant growth. Market Dynamics: The Immunology Market is primarily driven by the increasing prevalence of chronic diseases worldwide. Additionally, the rising research and development activities in the field of immunology, cou

Pharmacogenomics Market The Pharmacogenomics Market is estimated to be valued at US$ 33079.39 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Pharmacogenomics is the study of how an individual's genetic inheritance affects the body's response to drugs. It involves the analysis of a patient's DNA and RNA characteristics to optimize drug therapies, doses, and reduce adverse drug reactions. Pharmacogenomics helps physicians determine which medication options and dosages are most appropriate for a given individual. This enables personalized or precision medicine, which considers one's genetic makeup to guide treatment. Market Dynamics: The growth of the Pharmacogenomics Market is driven by two primary factors. Firstly, the rising demand for personalized medicine has boosted research related to pharmacogenomics. Traditional "one-size-fit

Research Antibodies Market The Research Antibodies Market is estimated to be valued at US$ 3785.5 Bn or Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Research antibodies are broadly used across various applications including proteomics, drug discovery, genomics and others. They help in identifying specific proteins and antibodies that play important roles in the physiological and pathological cellular processes. They are extensively used in research to detect, measure and purify proteins along with other cellular components. The common types of research antibodies include primary antibodies, secondary antibodies and isotype controls. Market Dynamics: Research antibodies market growth is driven by growing investments in biomedical research and rising focus on disease diagnosis and drug discovery. According to Pharmaceutical Research and Manufacturers of